SI3034512T1 - Process for the preparation of iron (III) casein N-acetyl-aspartyl complexes and their use in pharmaceutical compositions - Google Patents
Process for the preparation of iron (III) casein N-acetyl-aspartyl complexes and their use in pharmaceutical compositions Download PDFInfo
- Publication number
- SI3034512T1 SI3034512T1 SI201430535T SI201430535T SI3034512T1 SI 3034512 T1 SI3034512 T1 SI 3034512T1 SI 201430535 T SI201430535 T SI 201430535T SI 201430535 T SI201430535 T SI 201430535T SI 3034512 T1 SI3034512 T1 SI 3034512T1
- Authority
- SI
- Slovenia
- Prior art keywords
- casein
- acetyl
- iii
- iron
- chloride
- Prior art date
Links
- 239000005018 casein Substances 0.000 title claims abstract 16
- 235000021240 caseins Nutrition 0.000 title claims abstract 16
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title claims abstract 13
- 238000000034 method Methods 0.000 title claims abstract 13
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 title claims abstract 8
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 238000002360 preparation method Methods 0.000 claims abstract 4
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims abstract 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims abstract 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-Chlorosuccinimide Substances ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims 1
- 239000012320 chlorinating reagent Substances 0.000 claims 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- OHZZTXYKLXZFSZ-UHFFFAOYSA-I manganese(3+) 5,10,15-tris(1-methylpyridin-1-ium-4-yl)-20-(1-methylpyridin-4-ylidene)porphyrin-22-ide pentachloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3].C1=CN(C)C=CC1=C1C(C=C2)=NC2=C(C=2C=C[N+](C)=CC=2)C([N-]2)=CC=C2C(C=2C=C[N+](C)=CC=2)=C(C=C2)N=C2C(C=2C=C[N+](C)=CC=2)=C2N=C1C=C2 OHZZTXYKLXZFSZ-UHFFFAOYSA-I 0.000 claims 1
- PCUVYBUDIWDLNI-UHFFFAOYSA-N methyl n-(n'-chloro-n-methoxycarbonylcarbamimidoyl)carbamate Chemical compound COC(=O)NC(=NCl)NC(=O)OC PCUVYBUDIWDLNI-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 206010022971 Iron Deficiencies Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14386034.4A EP3034512B1 (en) | 2014-12-19 | 2014-12-19 | A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3034512T1 true SI3034512T1 (en) | 2018-04-30 |
Family
ID=52354737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201430535T SI3034512T1 (en) | 2014-12-19 | 2014-12-19 | Process for the preparation of iron (III) casein N-acetyl-aspartyl complexes and their use in pharmaceutical compositions |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20170340747A1 (enExample) |
| EP (1) | EP3034512B1 (enExample) |
| AP (1) | AP2017009801A0 (enExample) |
| AU (1) | AU2015365885B2 (enExample) |
| BR (1) | BR112017006621B1 (enExample) |
| CA (1) | CA2959226C (enExample) |
| CL (1) | CL2017001611A1 (enExample) |
| CO (1) | CO2017003313A2 (enExample) |
| CY (1) | CY1120037T1 (enExample) |
| DK (1) | DK3034512T3 (enExample) |
| EA (1) | EA031968B1 (enExample) |
| ES (1) | ES2655238T3 (enExample) |
| GE (2) | GEP20207081B (enExample) |
| HR (1) | HRP20171965T1 (enExample) |
| HU (1) | HUE035302T2 (enExample) |
| IL (1) | IL251449B (enExample) |
| LT (1) | LT3034512T (enExample) |
| MX (1) | MX374777B (enExample) |
| MY (1) | MY185391A (enExample) |
| NO (1) | NO3034512T3 (enExample) |
| PE (1) | PE20180660A1 (enExample) |
| PH (1) | PH12017500391B1 (enExample) |
| PL (1) | PL3034512T3 (enExample) |
| PT (1) | PT3034512T (enExample) |
| RS (1) | RS56714B1 (enExample) |
| SA (1) | SA517381261B1 (enExample) |
| SG (1) | SG11201702593TA (enExample) |
| SI (1) | SI3034512T1 (enExample) |
| SM (1) | SMT201800008T1 (enExample) |
| WO (1) | WO2016096203A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1009589B (el) * | 2018-04-05 | 2019-09-11 | Ιουλια Κλεωνος Τσετη | Φαρμακευτικο σκευασμα για την αντιμετωπιση της αναιμιας, σε καταλληλο περιεκτη, που διατηρει στεγανα διαχωρισμενα μεταξυ τους τα δραστικα συστατικα: συμπλοκο του τρισθενους σιδηρου με ν-ακετυλο-l-ασπαρτικη καζεϊνη και πενταϋδρικο φυλλινικο ασβεστιο |
| CN116655512A (zh) * | 2023-05-31 | 2023-08-29 | 江苏阿尔法药业股份有限公司 | 一种卡托普利的制备工艺 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB910321A (en) | 1960-02-25 | 1962-11-14 | Olivier Paul Gaudin | Improvements in and relating to a process for preparing ferrous salts of aspartic acid and medicines containing these salts |
| IT1150213B (it) | 1982-03-02 | 1986-12-10 | Italfarmaco Spa | Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche |
| IT1207996B (it) | 1986-03-18 | 1989-06-01 | Magis Farmaceutici | Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
| IT1297022B1 (it) | 1997-12-24 | 1999-08-03 | Chemi Spa | Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono |
| ITMO20040200A1 (it) | 2004-07-29 | 2004-10-29 | Biofer Spa | Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche. |
-
2014
- 2014-12-19 NO NO14386034A patent/NO3034512T3/no unknown
- 2014-12-19 ES ES14386034.4T patent/ES2655238T3/es active Active
- 2014-12-19 PT PT143860344T patent/PT3034512T/pt unknown
- 2014-12-19 HU HUE14386034A patent/HUE035302T2/en unknown
- 2014-12-19 EP EP14386034.4A patent/EP3034512B1/en active Active
- 2014-12-19 DK DK14386034.4T patent/DK3034512T3/en active
- 2014-12-19 SM SM20180008T patent/SMT201800008T1/it unknown
- 2014-12-19 SI SI201430535T patent/SI3034512T1/en unknown
- 2014-12-19 RS RS20171312A patent/RS56714B1/sr unknown
- 2014-12-19 LT LTEP14386034.4T patent/LT3034512T/lt unknown
- 2014-12-19 PL PL14386034T patent/PL3034512T3/pl unknown
-
2015
- 2015-10-22 AP AP2017009801A patent/AP2017009801A0/en unknown
- 2015-10-22 CA CA2959226A patent/CA2959226C/en active Active
- 2015-10-22 WO PCT/EP2015/074482 patent/WO2016096203A1/en not_active Ceased
- 2015-10-22 MY MYPI2017701462A patent/MY185391A/en unknown
- 2015-10-22 BR BR112017006621-1A patent/BR112017006621B1/pt active IP Right Grant
- 2015-10-22 US US15/536,855 patent/US20170340747A1/en not_active Abandoned
- 2015-10-22 PE PE2017000363A patent/PE20180660A1/es unknown
- 2015-10-22 SG SG11201702593TA patent/SG11201702593TA/en unknown
- 2015-10-22 EA EA201790902A patent/EA031968B1/ru unknown
- 2015-10-22 MX MX2017008100A patent/MX374777B/es active IP Right Grant
- 2015-10-22 AU AU2015365885A patent/AU2015365885B2/en active Active
- 2015-10-22 GE GEAP201514514A patent/GEP20207081B/en unknown
- 2015-10-22 GE GEAP201914514A patent/GEAP201914514A/en unknown
-
2017
- 2017-03-02 PH PH12017500391A patent/PH12017500391B1/en unknown
- 2017-03-29 IL IL251449A patent/IL251449B/en active IP Right Grant
- 2017-04-05 SA SA517381261A patent/SA517381261B1/ar unknown
- 2017-04-05 CO CONC2017/0003313A patent/CO2017003313A2/es unknown
- 2017-06-19 CL CL2017001611A patent/CL2017001611A1/es unknown
- 2017-12-19 HR HRP20171965TT patent/HRP20171965T1/hr unknown
- 2017-12-21 CY CY20171101341T patent/CY1120037T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500586A1 (en) | Pyrazolo [1,5-a] pyridine derivatives and their use as pesticides | |
| EP3712135A4 (en) | AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, PROCESS FOR THE PRODUCTION OF AN AZOLE DERIVATIVE, AGRICULTURAL AND HORTICULTURAL USE AGENT, AND MATERIAL PROTECTION AGENT FOR INDUSTRIAL USE | |
| MX2021005047A (es) | Compuestos de 6-azabenzimidazol sustituidos como inhibidores de hpk1. | |
| MY191160A (en) | Flame retardant mixtures, the production and the use thereof | |
| EP3947704A4 (en) | CELL-FREE PRODUCTION OF RIBONUCLEAN ACID | |
| MX394953B (es) | Proceso para la preparación de compuestos de 2,3-dihidrotiazolo[3,2-a]pirimidin-4-io ópticamente activo. | |
| MX392191B (es) | Derivados de heterociclos biciclicos condensados como agentes de control de plagas. | |
| IL289919A (en) | Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease | |
| EP4393911A4 (en) | PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYLFURFURAL | |
| SA517381763B1 (ar) | عملية لزيادة ثبات تركيب يشتمل على أحماض دهنية أوميغا-3 متعددة الروابط غير المشبعة | |
| EP3809847A4 (en) | Micellar delivery method | |
| SG11201906688VA (en) | Novel ester compounds, method for the production thereof and use thereof | |
| SI3034512T1 (en) | Process for the preparation of iron (III) casein N-acetyl-aspartyl complexes and their use in pharmaceutical compositions | |
| EP4221723A4 (en) | PROCESSES FOR PREPARATION OF IRON-BASED COMPLEXES | |
| MX2019006122A (es) | Metodo de hornear. | |
| EP4196111A4 (en) | PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL CO-CRYSTALS FOR ADDITIVE MANUFACTURING | |
| EP3737679C0 (en) | NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | |
| EP3464229A4 (en) | CONTINUOUS PROCESS FOR THE PRODUCTION OF MUCONIC ACID FROM ALDARIC ACID | |
| EA202192581A1 (ru) | Композиции d-метирозина и способы их получения | |
| MX2019006310A (es) | Procedimiento para la preparacion de una formulacion de 2-[(3-aminopropil)amino]etanotiol liofilizado. | |
| EP3950657A4 (en) | CARBON ACID MANUFACTURING PROCESS | |
| EP3858989A4 (en) | ALKALINE PHOSPHATASE COMPOSITION AND PRODUCTION PROCESSES FOR DEPHOSPHORYLATED NUCLEIC ACID AND LABELED NUCLEIC ACID | |
| EP3881848A4 (en) | PROCESS FOR PRODUCTION OF OROTIC ACID DERIVATIVE | |
| EA201990780A1 (ru) | Твердая форма соединения 4'-тио-2'-фторнуклеозид фосфамида и способ его получения и применения | |
| EP4410800A4 (en) | PROCESS FOR PRODUCING VINYLPHOSPHONIC ACID MONOESTER |